>
AI Lab powerd by REiLI
Image quality is at the very core of Fujifilm's more than 85-year legacy. The ability for clinicians to obtain and organize the highest quality patient images is vital to the entire care pathway: prevention, diagnosis and treatment. With our comprehensive and expanding portfolio of imaging technologies, we provide over 70 image recognition technologies and continue to evolve the technologies daily. Fujifilm develops AI technologies (REiLI) that strongly supports diagnostic imaging workflow, leveraging both deep learning AI and our image processing heritage.
Artificial Intelligence in Endoscopy
03-08-2020
Does AI the weapon to reduce colorectal cancer? Definitely to avoid wrong diagnoses said Alessandro Repici, Head of the Digestive Endoscopy Department, Humanitas Research Hospital in Milan.
During the emergency, ASST Vimercate Hospital chose REiLI, Fujifilm’s Artificial Intelligence, to support operators in the fight against COVID-19
02-07-2020
Artificial Intelligence is an essential tool for the healthcare operators on the front line in the fight against the Coronavirus pandemic. ASST Vimercate Hospital chose and implemented in the midst of the COVID-19 emergency REiLI, Fujifilm Medical Systems’ Artificial Intelligence.
REiLI TECHNOLOGY REVIEW- New release
30-06-2020
REiLI, which in Japanese means “intelligent and resourceful”, represents a new frontier in diagnostics and will improve medical care thanks to the collaboration between health professionals and Artificial Intelligence.
The union of the technologies of Image Processing and Artificial Intelligence will allow to obtain an even more accurate diagnosis.
REiLI USER'S VOICE
30-06-2020
During the emergency, the local health authority ASST Vimercate Hospital (Monza, Italy) chose REiLI, Fujifilm’s Artificial Intelligence platform, to support operators in the fight against COVID-19
Giovanni Delgrossi | Head of the IT Department of ASST Vimercate
Dr. Marcello Intotero | Director of the Department of Radiology and the Department of Diagnostic Services.
Using AI to better manage COVID-19
10-06-2020
At Lunit, we develop AI software that can assist radiologists in the interpretation of chest x-rays.
Fujifilm's New AI-based* Technology for Lung Nodule Detection Now Approved for Use in Japan
28-05-2020
Algorithm identifies pulmonary nodules** in chest CT scans to aid in lung cancer diagnosis
Fujifilm to develop AI-based technology to aid COVID-19-induced pneumonia diagnosis and assess the effectiveness of treatments
19-05-2020
Company commences joint research study with leading medical institutions in Japan, applying lesion quantification technology for pneumonia
ELUXEO meets AI in detection and characterisation function
29-04-2020
Fujifilm obtains CE mark on a software with new CAD EYE™ function for real time colon polyp characterisation utilising AI technology in Europe.
REiLI in support at the “Ca' Granda Ospedale Maggiore Policlinico” hospital in Milan
28-04-2020
Artificial Intelligence is an essential tool for the healthcare operators on the front line in the fight against the Coronavirus pandemic and this is why the new REiLI technology of Fujifilm Medical Systems was chosen and implemented by the “Ca' Granda Ospedale Maggiore Policlinico” hospital in Milan.
REiLI - Medical AI Technology | Fujifilm
15-04-2020
Fujifilm will develop AI technologies (REiLI) that strongly supports diagnostic imaging workflow, leveraging both deep learning AI and our image processing heritage.
Introducing CAD EYE for colonic polyp detection and characterisation, powered by REiLI
15-04-2020
Testo: The novel function called CAD EYE is specifically designed for evolving the ELUXEO series with an add-on to support endoscopic detection and characterisation in the colon.
Fujifilm launches CAD EYE
25-02-2020
Fujifilm acquires CE mark and launches CAD EYE, a function of colonic polyp detection utilizing AI technology, in Europe
REiLI TECHNOLOGY REVIEW
15-12-2018
Artificial Intelligence